Skip to main content

Advertisement

Log in

Broadening horizons: The role of ferroptosis in myocardial ischemia–reperfusion injury

  • Review
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Ferroptosis is a novel type of regulated cell death (RCD) discovered in recent years, where abnormal intracellular iron accumulation leads to the onset of lipid peroxidation, which further leads to the disruption of intracellular redox homeostasis and triggers cell death. Iron accumulation with lipid peroxidation is considered a hallmark of ferroptosis that distinguishes it from other RCDs. Myocardial ischemia–reperfusion injury (MIRI) is a process of increased myocardial cell injury that occurs during coronary reperfusion after myocardial ischemia and is associated with high post-infarction mortality. Multiple experiments have shown that ferroptosis plays an important role in MIRI pathophysiology. This review systematically summarized the latest research progress on the mechanisms of ferroptosis. Then we report the possible link between the occurrence of MIRI and ferroptosis in cardiomyocytes. Finally, we discuss and analyze the related drugs that target ferroptosis to attenuate MIRI and its action targets, and point out the shortcomings of the current state of relevant research and possible future research directions. It is hoped to provide a new avenue for improving the prognosis of the acute coronary syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Not applicable.

References

Download references

Funding

This work was supported by the National Natural Science Foundation of China (81804045), Natural Science Foundation of Shandong Province (ZR2021LZY038 and ZR2021LZY011), Shandong Provincial TCM Science and Technology Development Plan Project (2021M180), and Qilu School of Chinese Medicine Academic School Inheritance Project (Ip2022-17).

Author information

Authors and Affiliations

Authors

Contributions

Xijin Wei and Juan Zhang designed and directed the project. Ke Zhao and Xiaoshu Chen wrote the manuscript. Yujing Bian, Zhou Zhou, collected materials. All authors discussed the results and contributed to the final manuscript. The authors confirm that no paper mill and artificial intelligence was used.

Corresponding authors

Correspondence to Xijin Wei or Juan Zhang.

Ethics declarations

Ethical approval

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, K., Chen, X., Bian, Y. et al. Broadening horizons: The role of ferroptosis in myocardial ischemia–reperfusion injury. Naunyn-Schmiedeberg's Arch Pharmacol 396, 2269–2286 (2023). https://doi.org/10.1007/s00210-023-02506-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-023-02506-5

Keywords

Navigation